Roger Pomerantz - 30 Sep 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director
Signature
/s/ Roger Pomerantz
Issuer symbol
INDP
Transactions as of
30 Sep 2022
Net transactions value
$0
Form type
4
Filing time
03 Oct 2022, 16:30:46 UTC
Previous filing
29 Aug 2022
Next filing
29 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +81,000 $0.000000 81,000 30 Sep 2022 Common Stock 81,000 $2.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-half of the total shares on September 30, 2023 and thereafter the remaining shares vest and become exercisable on September 30, 2024.